TAP1 becomes a strong tumor prognostic marker that has demonstrated clear prognostic relevance in most cancer types and is also an emerging predictor of clinic prognosis and immunotherapy response among various cancers [15]. This evidence concerns the gene TAP1 and neoplasm.